[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Knapp, 2011 - Google Patents

Antimicrobial and Antitumor Properties of Free and Poly (Ethylene Glycol)-Poly (Lactic Acid) Encapsulated Silver N-Heterocyclic Carbene Complexes

Knapp, 2011

View PDF
Document ID
16485691767928608001
Author
Knapp A
Publication year

External Links

Snippet

Since the development of the first metal N-heterocyclic carbenes (NHC) by Ofele and Wanzlick in the 1960s, investigation into this area has grown dramatically, especially after the synthesis of the first stable free metal carbene in 1991 by Arduengo. Since that time …
Continue reading at etd.ohiolink.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Yang et al. Metal–organic frameworks for biomedical applications
Youngs et al. Nanoparticle encapsulated silver carbene complexes and their antimicrobial and anticancer properties: a perspective
Wen et al. Versatile nanoscale metal–organic frameworks (nMOFs): An emerging 3D nanoplatform for drug delivery and therapeutic applications
Maleki et al. The progress and prospect of zeolitic imidazolate frameworks in cancer therapy, antibacterial activity, and biomineralization
Rojas et al. Metal-organic frameworks: A novel platform for combined advanced therapies
Wang et al. Metal-organic frameworks for stimuli-responsive drug delivery
Abazari et al. A luminescent amine-functionalized metal–organic framework conjugated with folic acid as a targeted biocompatible pH-responsive nanocarrier for apoptosis induction in breast cancer cells
Beg et al. Nanoporous metal organic frameworks as hybrid polymer–metal composites for drug delivery and biomedical applications
Zhao et al. Redox-sensitive nanoscale coordination polymers for drug delivery and cancer theranostics
Liu et al. Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy
Wang et al. Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy
Chung et al. Magnetic responsive release of nitric oxide from an MOF-derived Fe3O4@ PLGA microsphere for the treatment of bacteria-infected cutaneous wound
Wang et al. Facile synthesis of the Cu, N-CDs@ GO-CS hydrogel with enhanced antibacterial activity for effective treatment of wound infection
Pourmadadi et al. Nanoscale metallic‐organic frameworks as an advanced tool for medical applications: Challenges and recent progress
Wang et al. Tunable Zeolitic Imidazolate Framework‐8 Nanoparticles for Biomedical Applications
EP2167097B1 (en) Metal complexes incorporated within biodegradable nanoparticles and their use
Mahmut et al. Medical applications and advancement of near infrared photosensitive indocyanine green molecules
Wang et al. Applications of metal–phenolic networks in nanomedicine: a review
Novio Design of targeted nanostructured coordination polymers (NCPS) for cancer therapy
Liu et al. X-ray-triggered CO release based on GdW10/MnBr (CO) 5 nanomicelles for synergistic radiotherapy and gas therapy
Chen et al. Polymeric systems containing supramolecular coordination complexes for drug delivery
AU2008279309B2 (en) Metal complexes incorporated within biodegradable nanoparticles and their use
de la Mata et al. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications
Han et al. Combining doxorubicin-conjugated polymeric nanoparticles and 5-aminolevulinic acid for enhancing radiotherapy against lung cancer
Chen et al. Porphyrinic metal-organic frameworks for biological applications